Institutional Ownership
Mirati Therapeutics Inc Cvr
CUSIP 604CVR105RIGQ1 2026
Earnings
Quarterly EPS and revenue are sourced from SEC XBRL financial statements. We ingest the top issuers first; this fills in as coverage expands (or this security isn't mapped to an SEC filer yet).